Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Insurers Are Rejecting Many PLA, MAAA Codes

Hope fades for labs expecting to get paid for new PLA, MAAA codes that PAMA authorized

>>CEO SUMMARY: Clinical labs developing innovative tests face a challenge getting paid. While Medicare may reimburse for these tests, some commercial payers and state Medicaid programs are not paying for new proprietary laboratory analyses (PLA) codes and multianalyte assays with algorithmic analyses (MAAA) codes. For labs running these tests, experts say the codes themselves bias …

Insurers Are Rejecting Many PLA, MAAA Codes Read More »

To access this post, you must purchase The Dark Report.